Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alexion Pharmaceuticals, Inc. (ALXN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alexion Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 899866.
Total stock buying since 2014: $437,497,430.
Total stock sales since 2014: $412,169,334.
Total stock option exercises since 2014: $47,629,632.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2020 | 550,902 | $43,418,749 | 32,449 | $4,771,020 | 24,066 | $2,860,725 |
2019 | 0 | $0 | 307,078 | $38,012,774 | 0 | $0 |
2018 | 10,000 | $1,207,900 | 59,447 | $6,969,140 | 0 | $0 |
2017 | 3,370,689 | $392,775,613 | 127,460 | $17,202,952 | 59,329 | $2,198,385 |
2016 | 0 | $0 | 124,312 | $17,235,284 | 53,449 | $2,891,440 |
2015 | 0 | $0 | 498,689 | $91,579,256 | 203,500 | $11,185,104 |
2014 | 510 | $95,168 | 1,361,896 | $236,398,908 | 1,216,245 | $28,493,978 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-12-29 | Bell Leonard | Option Ex | 28,968 | 22.90 | 663,367 |
2015-12-28 | Bell Leonard | Sale | 400 | 190.15 | 76,060 |
2015-12-28 | Bell Leonard | Option Ex | 400 | 22.90 | 9,160 |
2015-12-24 | Bell Leonard | Sale | 5,632 | 190.00 | 1,070,080 |
2015-12-24 | Bell Leonard | Option Ex | 5,632 | 22.90 | 128,972 |
2015-12-17 | Bell Leonard | Sale | 70,000 | 187.95 | 13,156,220 |
2015-12-17 | Bell Leonard | Option Ex | 70,000 | 22.90 | 1,603,000 |
2015-12-11 | Moriarty John B (EVP & General Counsel) | Sale | 943 | 184.09 | 173,601 |
2015-12-11 | Veneman Ann M | Sale | 895 | 187.48 | 167,794 |
2015-12-11 | Bell Leonard | Sale | 21,319 | 187.77 | 4,003,068 |
2015-12-11 | Norby R Douglas | Sale | 45,442 | 187.59 | 8,524,601 |
2015-12-08 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 950 | 190.00 | 180,500 |
2015-12-08 | Bell Leonard | Sale | 70,000 | 188.04 | 13,162,940 |
2015-11-25 | Bell Leonard | Sale | 35,000 | 181.79 | 6,362,755 |
2015-11-25 | Bell Leonard | Option Ex | 35,000 | 22.90 | 801,500 |
2015-11-10 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 3,000 | 173.34 | 520,020 |
2015-11-02 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 975 | 180.00 | 175,500 |
2015-11-02 | Parven Alvin S | Sale | 895 | 178.73 | 159,963 |
2015-11-02 | Bell Leonard | Sale | 35,000 | 180.12 | 6,304,200 |
2015-10-26 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 1,558 | 168.44 | 262,429 |
2015-09-10 | Thiel Carsten (SVP, EMEA & Asia Pacific) | Sale | 812 | 170.01 | 138,052 |
2015-09-09 | Miller Edward (SVP, Chief Compliance Officer) | Sale | 366 | 179.55 | 65,715 |
2015-09-09 | Bell Leonard | Sale | 1,050 | 180.10 | 189,105 |
2015-09-02 | O'neill Julie (EVP. Global Operations) | Sale | 647 | 171.76 | 111,128 |
2015-09-01 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 305 | 168.62 | 51,429 |
2015-08-07 | Moriarty John B (EVP & General Counsel) | Sale | 135 | 190.01 | 25,651 |
2015-08-07 | Hallal David (CEO) | Sale | 329 | 190.01 | 62,513 |
2015-08-07 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 163 | 190.01 | 30,971 |
2015-08-07 | Bell Leonard | Sale | 1,003 | 190.01 | 190,580 |
2015-08-05 | Moriarty John B (EVP & General Counsel) | Sale | 10,010 | 198.59 | 1,987,835 |
2015-08-05 | Moriarty John B (EVP & General Counsel) | Option Ex | 20,000 | 92.65 | 1,853,000 |
2015-08-04 | Hallal David (CEO) | Sale | 612 | 196.52 | 120,270 |
2015-08-04 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 185 | 196.52 | 36,356 |
2015-08-04 | Sinha Vikas (EVP & CFO) | Sale | 675 | 196.52 | 132,651 |
2015-08-04 | Bell Leonard | Sale | 2,200 | 196.52 | 432,344 |
2015-08-03 | Mackay Martin (EVP & Global Head of R&D) | Sale | 43,500 | 196.30 | 8,539,180 |
2015-08-03 | Mackay Martin (EVP & Global Head of R&D) | Option Ex | 43,500 | 140.83 | 6,126,105 |
2015-06-18 | Bell Leonard | Sale | 27,835 | 179.63 | 5,000,001 |
2015-06-11 | Moriarty John B (EVP & General Counsel) | Sale | 914 | 170.00 | 155,380 |
2015-05-20 | Monnet Dominique (SVP, Chief Marketing Officer) | Sale | 256 | 162.40 | 41,574 |
2015-05-14 | Mackay Martin (EVP & Global Head of R&D) | Sale | 4,056 | 160.33 | 650,298 |
2015-04-27 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 6,032 | 181.57 | 1,095,230 |
2015-03-19 | Bell Leonard (CEO) | Sale | 15,952 | 188.07 | 3,000,092 |
2015-03-02 | O'neill Julie (EVP. Global Operations) | Sale | 6,565 | 180.34 | 1,183,932 |
2015-03-02 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 228 | 180.34 | 41,117 |
2015-03-02 | Moriarty John B (EVP & General Counsel) | Sale | 280 | 180.34 | 50,495 |
2015-03-02 | Hallal David (Chief Operating Officer) | Sale | 730 | 180.34 | 131,648 |
2015-03-02 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 706 | 180.34 | 127,320 |
2015-03-02 | Mackay Martin (EVP & Global Head of R&D) | Sale | 370 | 180.34 | 66,725 |
2015-03-02 | Sinha Vikas (EVP & CFO) | Sale | 487 | 180.34 | 87,825 |
2015-03-02 | Bell Leonard (CEO) | Sale | 1,230 | 180.34 | 221,818 |
2015-02-27 | O'neill Julie (EVP. Global Operations) | Sale | 5,100 | .00 | 0 |
2015-02-10 | Monnet Dominique (SVP, Chief Marketing Officer) | Sale | 325 | 171.15 | 55,623 |
2015-02-10 | O'neill Julie (EVP. Global Operations) | Sale | 795 | 171.15 | 136,064 |
2015-02-10 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 1,500 | 171.15 | 256,725 |
2015-02-10 | Moriarty John B (EVP & General Counsel) | Sale | 1,490 | 171.15 | 255,013 |
2015-02-10 | Hallal David (Chief Operating Officer) | Sale | 1,980 | 171.15 | 338,877 |
2015-02-10 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 1,490 | 171.15 | 255,013 |
2015-02-10 | Mackay Martin (EVP & Global Head of R&D) | Sale | 3,897 | 174.03 | 678,194 |
2015-02-10 | Sinha Vikas (EVP & CFO) | Sale | 1,985 | 171.15 | 339,732 |
2015-02-10 | Bell Leonard (CEO) | Sale | 5,740 | 171.15 | 982,401 |
2015-02-09 | Moriarty John B (EVP & General Counsel) | Sale | 1,455 | 174.16 | 253,402 |
2015-02-09 | Hallal David (Chief Operating Officer) | Sale | 2,920 | 173.93 | 507,875 |
2015-02-09 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 1,665 | 173.75 | 289,293 |
2015-02-09 | Sinha Vikas (EVP & CFO) | Sale | 2,703 | 174.63 | 472,038 |
2015-02-09 | Bell Leonard (CEO) | Sale | 8,660 | 173.98 | 1,506,666 |
2015-02-04 | Hallal David (Chief Operating Officer) | Sale | 608 | 174.38 | 106,023 |
2015-02-04 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 207 | 173.59 | 35,932 |
2015-02-04 | Sinha Vikas (EVP & CFO) | Sale | 676 | 174.37 | 117,874 |
2015-02-04 | Bell Leonard (CEO) | Sale | 2,223 | 173.41 | 385,490 |
2015-02-03 | Hallal David (Chief Operating Officer) | Sale | 765 | 174.02 | 133,125 |
2015-02-03 | Sinha Vikas (EVP & CFO) | Sale | 895 | 174.06 | 155,783 |
2015-02-03 | Bell Leonard (CEO) | Sale | 3,000 | 174.25 | 522,750 |
2014-12-18 | Hallal David (Chief Operating Officer) | Sale | 5,494 | 182.03 | 1,000,072 |
2014-12-18 | Sinha Vikas (EVP & CFO) | Sale | 5,493 | 182.08 | 1,000,165 |
2014-12-18 | Bell Leonard (CEO) | Sale | 13,735 | 182.03 | 2,500,182 |
2014-12-17 | Bell Leonard (CEO) | Sale | 16,680 | 177.96 | 2,968,422 |
2014-12-17 | Bell Leonard (CEO) | Option Ex | 16,680 | 22.90 | 381,972 |
2014-12-15 | Brennan David R | Buy | 500 | 186.99 | 93,495 |
2014-12-11 | Moriarty John B (EVP & General Counsel) | Sale | 3,570 | 195.53 | 698,042 |
2014-12-11 | Veneman Ann M | Sale | 1,235 | 193.03 | 238,392 |
2014-12-09 | Bell Leonard (CEO) | Sale | 16,665 | 199.94 | 3,332,000 |
2014-12-09 | Bell Leonard (CEO) | Option Ex | 16,665 | 22.90 | 381,628 |
2014-12-08 | Bell Leonard (CEO) | Sale | 59,934 | 198.57 | 11,900,854 |
2014-12-08 | Bell Leonard (CEO) | Option Ex | 59,934 | 20.44 | 1,225,050 |
2014-12-05 | Bell Leonard (CEO) | Sale | 56,721 | 197.59 | 11,207,785 |
2014-12-05 | Bell Leonard (CEO) | Option Ex | 56,721 | 17.98 | 1,019,843 |
2014-12-04 | Keller William R | Sale | 5,000 | 196.25 | 981,250 |
2014-12-04 | Carmichael Clare (SVP, Chief HR Officer) | Sale | 10,000 | 196.25 | 1,962,500 |
2014-12-04 | Carmichael Clare (SVP, Chief HR Officer) | Option Ex | 10,000 | 57.02 | 570,200 |
2014-12-03 | Sinha Vikas (EVP & CFO) | Sale | 50,000 | 199.08 | 9,954,000 |
2014-12-03 | Sinha Vikas (EVP & CFO) | Option Ex | 50,000 | 19.44 | 972,000 |
2014-12-02 | Sinha Vikas (EVP & CFO) | Sale | 25,000 | 200.16 | 5,004,000 |
2014-12-02 | Sinha Vikas (EVP & CFO) | Option Ex | 25,000 | 17.98 | 449,500 |
2014-11-20 | Bell Leonard (CEO) | Sale | 5,210 | 191.96 | 1,000,111 |
2014-11-11 | Parven Alvin S | Sale | 15,000 | 195.66 | 2,934,900 |
2014-11-11 | Parven Alvin S | Option Ex | 15,000 | 18.01 | 270,150 |
2014-11-06 | Sinha Vikas (EVP & CFO) | Sale | 5,693 | 195.00 | 1,110,135 |
2014-11-06 | Sinha Vikas (EVP & CFO) | Option Ex | 5,693 | 17.98 | 102,360 |
2014-11-03 | Islam Saqib (SVP, Chief Strat & Port. Off.) | Sale | 28,125 | 190.51 | 5,358,093 |
2014-11-03 | Islam Saqib (SVP, Chief Strat & Port. Off.) | Option Ex | 28,125 | 89.23 | 2,509,593 |
2014-11-03 | Hallal David (Chief Operating Officer) | Sale | 30,000 | 190.01 | 5,700,300 |
2014-11-03 | Hallal David (Chief Operating Officer) | Option Ex | 30,000 | 20.27 | 608,250 |
2014-11-03 | Mackay Martin (EVP & Global Head of R&D) | Sale | 9,375 | 191.52 | 1,795,500 |
2014-11-03 | Mackay Martin (EVP & Global Head of R&D) | Option Ex | 9,375 | 104.86 | 983,062 |
2014-11-03 | Sinha Vikas (EVP & CFO) | Sale | 30,000 | 191.98 | 5,759,400 |
2014-11-03 | Sinha Vikas (EVP & CFO) | Option Ex | 30,000 | 17.96 | 538,800 |
2014-10-31 | Sinha Vikas (EVP & CFO) | Sale | 19,307 | 195.18 | 3,768,340 |
2014-10-31 | Sinha Vikas (EVP & CFO) | Option Ex | 19,307 | 17.80 | 343,761 |
2014-10-27 | Moriarty John B (SVP & General Counsel) | Sale | 10,000 | 189.75 | 1,897,450 |
2014-10-27 | Moriarty John B (SVP & General Counsel) | Option Ex | 10,000 | 92.65 | 926,500 |
2014-10-27 | Squinto Stephen P (EVP, Chief Global Ops. Officer) | Sale | 5,910 | 188.68 | 1,115,098 |
2014-10-27 | Squinto Stephen P (EVP, Chief Global Ops. Officer) | Option Ex | 5,550 | 60.77 | 337,273 |
2014-10-17 | Burns M Michele | Buy | 10 | 167.32 | 1,673 |
2014-10-06 | Moriarty John B (SVP & General Counsel) | Sale | 10,000 | 179.00 | 1,790,000 |
2014-10-06 | Moriarty John B (SVP & General Counsel) | Option Ex | 10,000 | 95.65 | 956,500 |
2014-10-03 | Squinto Stephen P (EVP, Chief Global Ops. Officer) | Sale | 10,025 | 172.45 | 1,728,811 |
2014-10-03 | Squinto Stephen P (EVP, Chief Global Ops. Officer) | Option Ex | 10,025 | 42.66 | 427,666 |
2014-09-26 | Bell Leonard (CEO) | Sale | 60,000 | 165.66 | 9,939,600 |
2014-09-24 | Squinto Stephen P (EVP, Chief Global Ops. Officer) | Sale | 76 | 159.50 | 12,122 |
2014-09-18 | Bell Leonard (CEO) | Sale | 12,388 | 161.45 | 2,000,042 |
2014-09-16 | Bell Leonard (CEO) | Sale | 32,047 | 160.20 | 5,133,929 |
2014-09-16 | Bell Leonard (CEO) | Option Ex | 32,047 | 17.65 | 565,629 |
2014-09-10 | Bell Leonard (CEO) | Sale | 12,199 | 165.38 | 2,017,470 |
2014-09-08 | Bell Leonard (CEO) | Sale | 21,214 | 165.11 | 3,502,643 |
2014-09-08 | Bell Leonard (CEO) | Option Ex | 21,214 | 17.98 | 381,427 |
2014-09-05 | Bell Leonard (CEO) | Sale | 90,919 | 163.76 | 14,888,713 |
2014-09-05 | Bell Leonard (CEO) | Option Ex | 90,919 | 17.98 | 1,634,723 |
2014-09-04 | Bell Leonard (CEO) | Sale | 85,668 | 167.81 | 14,375,947 |
2014-09-04 | Bell Leonard (CEO) | Option Ex | 85,668 | 17.98 | 1,540,310 |
2014-09-02 | Carmichael Clare (SVP, Chief HR Officer) | Sale | 304 | 169.46 | 51,515 |
2014-08-27 | Bell Leonard (CEO) | Sale | 5,912 | 169.17 | 1,000,133 |
2014-08-25 | Rummelt Andreas | Sale | 5,052 | 170.53 | 861,517 |
2014-08-25 | Rummelt Andreas | Option Ex | 5,052 | 36.90 | 186,393 |
2014-08-15 | Bell Leonard (CEO) | Sale | 35,000 | 170.06 | 5,952,100 |
2014-08-15 | Bell Leonard (CEO) | Option Ex | 35,000 | 17.65 | 617,750 |
2014-08-14 | Bell Leonard (CEO) | Sale | 35,000 | 166.29 | 5,820,045 |
2014-08-14 | Bell Leonard (CEO) | Option Ex | 35,000 | 17.65 | 617,750 |
2014-08-13 | Bell Leonard (CEO) | Sale | 24,542 | 162.40 | 3,985,694 |
2014-08-13 | Bell Leonard (CEO) | Option Ex | 24,542 | 17.65 | 433,166 |
2014-08-12 | Bell Leonard (CEO) | Sale | 80,458 | 160.26 | 12,894,601 |
2014-08-12 | Bell Leonard (CEO) | Option Ex | 80,458 | 17.65 | 1,420,083 |
2014-08-04 | Hallal David (EVP, Chief Commercial Officer) | Sale | 1,349 | 158.00 | 213,142 |
2014-08-04 | Carmichael Clare (SVP, Chief HR Officer) | Sale | 184 | 158.23 | 29,114 |
2014-08-04 | Sinha Vikas (EVP & CFO) | Sale | 1,525 | 157.82 | 240,675 |
2014-08-04 | Squinto Stephen P (EVP, Chief Global Ops. Officer) | Sale | 1,662 | 157.42 | 261,632 |
2014-08-04 | Bell Leonard (CEO) | Sale | 5,145 | 157.88 | 812,292 |
2014-07-30 | Bell Leonard (CEO) | Sale | 20,489 | 166.25 | 3,406,234 |
2014-07-30 | Bell Leonard (CEO) | Option Ex | 20,489 | 17.65 | 361,630 |
2014-07-29 | Bell Leonard (CEO) | Sale | 1,200 | 164.93 | 197,916 |
2014-07-29 | Bell Leonard (CEO) | Option Ex | 1,200 | 17.65 | 21,180 |
2014-07-28 | Bell Leonard (CEO) | Sale | 105,600 | 163.39 | 17,254,195 |
2014-07-28 | Bell Leonard (CEO) | Option Ex | 105,600 | 17.65 | 1,863,839 |
2014-06-20 | Bell Leonard (CEO) | Sale | 90,280 | 163.06 | 14,720,966 |
2014-06-20 | Bell Leonard (CEO) | Option Ex | 90,280 | 11.92 | 1,076,137 |
2014-06-12 | Mackay Martin (EVP & Global Head of R&D) | Sale | 25,000 | 166.54 | 4,163,575 |
2014-06-12 | Mackay Martin (EVP & Global Head of R&D) | Option Ex | 25,000 | 104.86 | 2,621,500 |
2014-06-05 | Keller William R | Sale | 3,425 | 170.00 | 582,250 |
2014-06-05 | Keller William R | Option Ex | 3,425 | 96.35 | 329,998 |
2014-06-04 | Veneman Ann M | Sale | 1,236 | 170.01 | 210,132 |
2014-05-27 | Bell Leonard (CEO) | Sale | 70,000 | 166.31 | 11,641,490 |
2014-05-27 | Bell Leonard (CEO) | Option Ex | 70,000 | 11.92 | 834,400 |
2014-05-20 | Bell Leonard (CEO) | Sale | 70,000 | 156.78 | 10,974,810 |
2014-05-20 | Bell Leonard (CEO) | Option Ex | 70,000 | 11.11 | 777,350 |
2014-05-14 | Mackay Martin (EVP & Global Head of R&D) | Sale | 3,574 | 160.85 | 574,877 |
2014-05-13 | Parven Alvin S | Sale | 12,276 | 160.78 | 1,973,735 |
2014-05-13 | Parven Alvin S | Option Ex | 12,276 | 16.83 | 206,605 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALXN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alexion Pharmaceuticals, Inc. (symbol ALXN, CIK number 899866) see the Securities and Exchange Commission (SEC) website.